Immunocytochemistry versus molecular fingerprinting of metastases

Cytopathology

Volumn 14, Issue 4, 2003, Pages 186-190

  Salto Tellez, M ^a,b   Zhang, D ^a   Chiu, L L ^b   Wang, S C ^b   Nilsson, B ^a   Koay, E S C ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Allelic imbalance; Immunocytochemistry; Microsatellites; Synchronous tumours

Indexed keywords

MICROSATELLITE DNA;

AGED; ALLELIC IMBALANCE; ARTICLE; CANCER CYTODIAGNOSIS; CASE REPORT; COLON ADENOCARCINOMA; COLON MUCOSA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG CANCER; LUNG METASTASIS; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA FINGERPRINTING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICROSATELLITE REPEATS; NEOPLASM METASTASIS; NEOPLASMS, MULTIPLE PRIMARY; TUMOR MARKERS, BIOLOGICAL;

EID: 0042661217     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2003.00076.x     Document Type: Article

References (20)

1. Bagg A, Kallakury BV. Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 1999; 112: S76-92.
2. Bennicelli JL, Barr FG. Genetics and the biologic basis of sarcomas. Curr Opin Oncol 1999; 11: 267-74.
3. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000; 2: 20-8.
4. Greiner TC. Polymerase chain reaction: uses and potential applications in cytology. Diagn Cytopathol 1992; 8: 61-64.
5. Pestaner JP, Bibbo M, Bobroski L, Seshamma T, Bagasra O. Potential of the in situ polymerase chain reaction in diagnostic cytology. Acta Cytol 1994; 38: 676-80.
6. Al Shanqeety O, Mourad WA. Diagnosis of peripheral T-cell lymphoma by fine needle aspiration biopsy: a cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2000; 23:375-9
7. Braunschweig R, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, Benhattar J. Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol 2001; 25: 225-30.
8. Stewart CJ, Jackson R, Farquharson M, Richmond J. Fine needle aspiration cytology of extranodal lymphoma. Diagn Cytopathol 1998; 19: 260-6.
9. Kuhler-Obbarius C, Milde-Langosch K, Loning T, Stegner HE. Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System. Acta Cytol 1994; 38: 681-6.
10. Medintz IL, Lee CC, Wong WW, Pirkola K, Sidransky D, Mathies RA. Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res 2000; 10: 1211-8.
11. Chuaqui R, Vargas MP, Castiglioni T et al. Detection of heterozygosity loss in microdissected fine needle aspiration specimens of breast carcinoma. Acta Cytol 1996; 40: 642-8.
12. Simsir A, Palacios D, Linehan WM, Merino MJ, Abati A. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues. Diagn Cytopathol 2001; 24: 328-32.
13. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13:962-72
14. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol 2000; 31: 980-7.
15. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403-39.
16. http://www.immunoquery.com/index.cfm
17. Heatley MK. Keratin expression in human tissues and neoplasms. Histopathology 2002; 41: 365-6
18. Fong KM, Zimmerman PV, Smith PJ. Tumor progression and loss of heterozygosity at 5 q and 18 q in non-small cell lung cancer. Cancer Res 1995; 55: 220-3.
19. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57.
20. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119: 921-8.